APA (7th ed.) Citation

FA, M., S, W., HA, M., C, L., S, M., R, H., . . . C, D. (2024). Evaluation of intranasal TLR2/6 agonist INNA-051: Safety, tolerability and proof of pharmacology. ERJ open research, 10(6), . https://doi.org/10.1183/23120541.00199-2024

Chicago Style (17th ed.) Citation

FA, Mercuri, et al. "Evaluation of Intranasal TLR2/6 Agonist INNA-051: Safety, Tolerability and Proof of Pharmacology." ERJ Open Research 10, no. 6 (2024). https://doi.org/10.1183/23120541.00199-2024.

MLA (9th ed.) Citation

FA, Mercuri, et al. "Evaluation of Intranasal TLR2/6 Agonist INNA-051: Safety, Tolerability and Proof of Pharmacology." ERJ Open Research, vol. 10, no. 6, 2024, https://doi.org/10.1183/23120541.00199-2024.